Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Interest coverage

Interest coverage at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-1.4×-3.2×
Alkermes logo
AlkermesALKS
5.8×-17.8×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-13×-15.9×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
2.5×-5.9×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
101×+77.4×
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-5.1×-5.4×

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

ebit/interest expense=13.5×

Based on trailing twelve months.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s interest coverage?
Harmony Biosciences Holdings, Inc. (HRMY) reported interest coverage of 13.5× in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s interest coverage changed year-over-year?
Harmony Biosciences Holdings, Inc.'s interest coverage increased by 16.2% year-over-year, from 11.6× to 13.5×.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s interest coverage?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s interest coverage has grown at a 40.8% compound annual growth rate (CAGR), from 3.6× to 14.2×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.